Abstract: The invention relates to a composition for mineralising carbon dioxide and nitrogen oxide gases, which comprises a mixture of magnesium (between 1 and 25%), iron (between 1 and 23%), calcium monoxide (between 1 and 25%), titanium dioxide (between 0.1 and 11%) and silicon dioxide (between 16 and 75%), with a particle diameter between 100 nm and 4000 ?m. The composition causes the mineralisation of carbon dioxide (CO2) and of the gaseous chemical compounds known as “nitrogen oxides” (NOx) in the atmosphere. This composition can be added or mixed as an additive in paints, dyes, resins and elastic polymers (gum and natural rubber) in parts with wear, and for any type of covering.

Abstract: The invention relates to a composition for mineralising carbon dioxide and nitrogen oxide gases, which comprises a mixture of magnesium (between 1 and 25%), iron (between 1 and 23%), calcium monoxide (between 1 and 25%), titanium dioxide (between 0.1 and 11%) and silicon dioxide (between 16 and 75%), with a particle diameter between 100 nm and 4000 ?m. The composition causes the mineralisation of carbon dioxide (CO2) and of the gaseous chemical compounds known as “nitrogen oxides” (NOx) in the atmosphere. This composition can be added or mixed as an additive in paints, dyes, resins and elastic polymers (gum and natural rubber) in parts with wear, and for any type of covering.

Abstract: A pharmaceutical composition for treating urinary incontinence and/or enuresis, which comprises at least 0.5-20 wt % of a mixture of flavonoids, 2-20 wt % of condensed tannins or proantocyanidins and 0.3-60 wt % of gamma aminobutyric acid (GABA), with respect to the total composition. The composition additionally comprises at least 50% of a Humulus lupulus extract. The composition is used for preparing a medicine for treating incontinence and/or enuresis, in particular enuresis in children, as well as in adults or the elderly who have urine leaks such as incontinence due to stress or urgency.

Abstract: The present invention relates to a pharmaceutical composition for treating urinary incontinence and/or enuresis, which comprises at least 0.5-20 wt % of a mixture of flavonoids, 2-20 wt % of condensed tannins or proantocyanidins and 0.3-60 wt % of gamma aminobutyric acid (GABA), with respect to the total composition. Said composition additionally comprises at least 0% of a Humulus lupulus extract. The present invention also relates to the use of said composition for preparing a medicine for treating incontinence and/or enuresis, in particular enuresis in children, as well as in adults or the elderly who have urine leaks such as incontinence due to stress or urgency.